NCT03332017
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03332017
Title A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma
Acronym ROSEWOOD
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors BeiGene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NZL | ITA | GBR | FRA | ESP | DEU | CZE | CAN | BGR | AUS

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field